Skip to main content

Table 4 Median laboratory values (Q1–Q3) at different time stages

From: Epidemiology, causes, evolution and outcome in a single-center cohort of 1116 critically ill patients with hypoxic hepatitis

Variable

At start of HH

At T-ASTmax

AST (U/L)

185.0 (155.0–185.0)

521.2 (269.1–1581.6)

ALT (U/L)

120.8 (70.1–193.5)

317.0 (143.5–924.5)

LDH (U/L)

691.8 (465.8–1025.7)

1106.4 (624.8–2602.8)

Bilirubin (mg/dL)

0.8 (0.5–1.6)

1.0 (0.6–2.0)

GGT (U/L)

73.1 (36.2–160.4)

82.5 (41.7–167.0)

AP (U/L)

88.2 (61.8–150.9)

94.0 (62.9–167.0)

Lipase (U/L)

32.4 (18.9–58.9)

33.5 (18.5–66.4)

INR

1.4 (1.2–1.8)

1.6 (1.3–2.2)

PC (103/µL)

165.7 (103.6–241.0)

146.0 (79.5–218.0)

WBC (103/µL)

12.5 (8.8–17.6)

13.2 (9.0–18.5)

Hb (g/dL)

10.1 (8.8–12.0)

9.8 (8.6–11.5)

CK (U/L)

214.0 (77.2–747.2)

322.2 (105.1–1102.9)

Creatinine (mg/dL)

1.4 (0.9–2.1)

1.4 (0.9–2.2)

Urea (mg/dL)

57.1 (38.9–91.3)

61.6 (40.6–96.4)

Lactate (mg/dL)

31.3 (16.2–62.2)

27.4 (14.7–56.2)

  1. AP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, CK creatine kinase, GGT gamma-glutamyl transpeptidase, Hb hemoglobin, INR international normalized ratio, LDH lactate dehydrogenase, PC platelet count, WBC white blood cell count